JUN 06, 2018 05:54 AM PDT

Computer Simulations Offer Alternative Methods for Diabetic Drugs

WRITTEN BY: Nouran Amin

The Governor's Chair for Molecular Biophysics at the University of Tennessee (Knoxville), Jeremy Smith, and the director for the Center for Molecular Biophysics at Oak Ridge National Laboratory, has collaborated with a research team from UT Health Science Center to find a chemical substance that may lower glucose levels in the same efficacy as the common diabetic metformin but with the possibility of being administered in lower dose.

Smith, in collaboration with Jerome Baudry, of the University of Alabama (Huntsville) as well as graduate student Karan Kapoor, from the University of Illinois at Urbana-Champaign, studied high-performance computing to develop sophisticated simulations that suggest chemicals that could activate GPRC6A, which is protein that regulates sugar levels while at the same time corrects abnormalities in pancreatic insulin secretion, glucose uptake into skeletal muscle, and the regulation of glucose and fat metabolism in the liver.

"This chemical compound lowers sugar levels in mice as effectively as metformin, but with a 30-times lower dose," Smith said. "It therefore is a good starting point for the development of a new and effective drug to fight diabetes."

Wolrdwide, about 400 million people suffer from Type 2 diabetes. The global cost of treatment and management of this metabolic disorder is estimated to be a trillion dollars annually. Metformin, a common diabetic drug that works to reduce the liver's production of sugar and lessen the risk of mortality, is currently first-line medication treatment by physicians. However, there remains a dire need for an alternative treatment option for patients who do not respond to metformin as well as others.

 

The computations derived from the research study confirmed that multiple chemical compounds, tested each by the Quarles laboratory at UTHSC, may activate the GPRC6A protein. Furthermore, a team of UTHSC medicinal investigators utilized the results from the research study to synthesize related molecules for pre-clinical testing use. The chemical compound by the name of ‘DJ-V-159’ was identified and concluded to be highly potent in inducing insulin secretion and decreasing glucose levels in mouse models.

 

Source: University of Tennessee at Knoxville

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 18, 2019
Drug Discovery & Development
OCT 18, 2019
Novel Therapy Shows Promise for Acute Migraines
In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic...
OCT 18, 2019
Drug Discovery & Development
OCT 18, 2019
Can LSD Treat Addiction?
Modern medicine commonly refers to addiction as a brain disease caused by drugs and other negative stimuli. However, evidence is surmounting that addiction...
OCT 18, 2019
Technology
OCT 18, 2019
How Bitcoins Can Advance Medication Usage
Will futuristic concepts from the world of technology likely find a place in our medicine cabinet? Maybe! The new concept has been known as ‘cryptoph...
OCT 18, 2019
Drug Discovery & Development
OCT 18, 2019
Injectable Implant Drug Shows Promise for HIV Treatment
In a study published in Nature Communications, alternative treatment was shown to have promising results for HIV as opposed to a daily pill regimen. Scient...
OCT 18, 2019
Cardiology
OCT 18, 2019
Heart Attacks Without The Risk
Following a heart attack, as the heart heals, scar tissue forms. This issue is less flexible than healthy heart tissue and may encumber the heart's abi...
OCT 18, 2019
Genetics & Genomics
OCT 18, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
Loading Comments...